Year to Date Performance

While we close out Q3, it’s probably a good idea to review my performance to date. As of the close on September 30^th, my performance year to date is +31.28%. The monthly gains / losses are as follows:

January -0.3%

February +4.67%

March +5.03%

April +5.13%

May +5.13%

June -0.37%

July +2.3%

August +3.3%

September +6.39%

I believe I’ve done a decent job this year in generating a more consistent monthly performance. Prior years, my monthly performance has been lumpy with some good and some disastrous months. I’ll be nice to determine my alpha (abnormal rate of return) in order see if I’m generating returns with low risk. Maybe my next project…

My largest position is currently Spreadtrum Communications (Ticker: SPRD), which is waiting for PRC regulatory approval in order to close followed by Constellation Brands (Ticker: STZ), Apple (Ticker: AAPL) and VISA (Ticker: V). I also have smaller positions in the mix such as Biogen Idec (Ticker: BIIB), Master Card (Ticker: MA) and Vertex Pharmaceuticals (Ticker: VRTX). The portfolio is basically divided into special situations and growth plays.

So I’m just researching some new special situation plays while I wait for Onyx Pharmaceuticals (Ticker: ONXX) and Spreadtrum Communications to close.